© 1998 by Oxford University Press
Serum insulin-like growth factor-I levels and prostate cancer risk-- interpreting the evidence
P Cohen
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Raina, M.-J. Blouin, R. P. Singh, N. Majeed, G. Deep, L. Varghese, L. M. Glode, N. M. Greenberg, D. Hwang, P. Cohen, et al. Dietary Feeding of Silibinin Inhibits Prostate Tumor Growth and Progression in Transgenic Adenocarcinoma of the Mouse Prostate Model Cancer Res., November 15, 2007; 67(22): 11083 - 11091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M Martin Commentary: Prostate cancer is omnipresent, but should we screen for it? Int. J. Epidemiol., April 1, 2007; 36(2): 278 - 281. [Full Text] [PDF]
|
|
|
|
 |
|
 S Zhang, X Li, R Burghardt, R Smith III, and S H Safe Role of estrogen receptor (ER) {alpha} in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells J. Mol. Endocrinol., December 1, 2005; 35(3): 433 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Wadsworth, J. M. Carroll, R. A. Mallinson, C. T. Roberts Jr., and C. E. Roselli Saw Palmetto Extract Suppresses Insulin-Like Growth Factor-I Signaling and Induces Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase Phosphorylation in Human Prostate Epithelial Cells Endocrinology, July 1, 2004; 145(7): 3205 - 3214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Skalkidou, E. Petridou, E. Papathoma, H. Salvanos, S. Kedikoglou, G. Chrousos, and D. Trichopoulos Determinants and Consequences of Major Insulin-like Growth Factor Components among Full-Term Healthy Neonates Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 860 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Roberts, D. J. Jacobson, C. J. Girman, T. Rhodes, G. G. Klee, M. M. Lieber, and S. J. Jacobsen Insulin-like Growth Factor I, Insulin-like Growth Factor Binding Protein 3, and Urologic Measures of Benign Prostatic Hyperplasia Am. J. Epidemiol., May 1, 2003; 157(9): 784 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Colao, C. Di Somma, S. Spiezia, M. Filippella, R. Pivonello, and G. Lombardi Effect of Growth Hormone (GH) and/or Testosterone Replacement on the Prostate in GH-Deficient Adult Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Lacey Jr., A. W. Hsing, C.-M. Fillmore, S. Hoffman, K. J. Helzlsouer, and G. W. Comstock Null Association between Insulin-like Growth Factors, Insulin-like Growth Factor-binding Proteins, and Prostate Cancer in a Prospective Study Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1101 - 1102. [Full Text] [PDF]
|
|
|
|
|
|
J. Khosravi, A. Diamandi, J. Mistry, and A. Scorilas Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 in Benign Prostatic Hyperplasia and Prostate Cancer J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 694 - 699. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Harman, E. J. Metter, M. R. Blackman, P. K. Landis, and H. B. Carter Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4258 - 4265. [Abstract] [Full Text]
|
|
|
|
|
|
A. Colao, P. Marzullo, S. Spiezia, A. Giaccio, D. Ferone, G. Cerbone, A. Di Sarno, and G. Lombardi Effect of Two Years of Growth Hormone and Insulin-Like Growth Factor-I Suppression on Prostate Diseases in Acromegalic Patients J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3754 - 3761. [Abstract] [Full Text]
|
|
|
|
|
|
P. Finne, A. Auvinen, H. Koistinen, W.-M. Zhang, L. Määttänen, S. Rannikko, T. Tammela, M. Seppälä, M. Hakama, and U.-H. Stenman Insulin-Like Growth Factor I Is Not a Useful Marker of Prostate Cancer in Men with Elevated Levels of Prostate-Specific Antigen J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2744 - 2747. [Abstract] [Full Text]
|
|
|
|
|
|
A. Diamandi, J. Mistry, R. G. Krishna, and J. Khosravi Immunoassay of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3): New Means to Quantifying IGFBP-3 Proteolysis J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2327 - 2333. [Abstract] [Full Text]
|
|
|
|
|
|
W. Xue, R. A. Irvine, M. C. Yu, R. K. Ross, G. A. Coetzee, and S. A. Ingles Susceptibility to Prostate Cancer: Interaction between Genotypes at the Androgen Receptor and Prostate-specific Antigen Loci Cancer Res., February 1, 2000; 60(4): 839 - 841. [Abstract] [Full Text]
|
|
|
|
|
|
A. Colao, P. Marzullo, S. Spiezia, D. Ferone, A. Giaccio, G. Cerbone, R. Pivonello, C. Di Somma, and G. Lombardi Effect of Growth Hormone (GH) and Insulin-Like Growth Factor I on Prostate Diseases: An Ultrasonographic and Endocrine Study in Acromegaly, GH Deficiency, and Healthy Subjects J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1986 - 1991. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Kaplan, S. Mohan, P. Cohen, B. A. Foster, and N. M. Greenberg The Insulin-like Growth Factor Axis and Prostate Cancer: Lessons from the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model Cancer Res., May 1, 1999; 59(9): 2203 - 2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schaefer, G. D. Friedman, C. P. Quesenberry Jr., N. Orentreich, J. H. Vogelman;, J. M. Chan, M. J. Stampfer, E. Giovannucci, and M. Pollak; IGF-I and Prostate Cancer Science, October 9, 1998; 282(5387): 199a - 199. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||